WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


                        ALLIED HEALTHCARE PRODUCTS, INC.

             (Exact Name of Registrant as Specified in Its Charter)

                    Delaware                                    0-19266                      25-1370721
----------------------------------------------         ------------------------       ----------------------
(State or Other Jurisdiction of Incorporation)         (Commission File Number)         (I.R.S. Employer
                                                                                      Identification Number)

                 1720 Sublette Avenue, St. Louis, Missouri 63110
          (Address, Including Zip Code, of Principal Executive Offices

              (Registrant's Telephone Number, Including Area Code)

          (Former Name or Former Address, if Changed Since Last Report)

Item 4. Changes in Registrant's Certifying Accountant

(a)      Previous independent accountants

         (i) On November 17, 2003, Allied Healthcare Products, Inc. (the
         "Company") dismissed PricewaterhouseCoopers LLP as its independent
         accountants. The Registrant's Audit Committee and Board of Directors
         participated in and approved the decision to change independent

         (ii) The reports of PricewaterhouseCoopers LLP on the financial
         statements for the past two fiscal years contained no adverse opinion
         or disclaimer of opinion and were not qualified or modified as to
         uncertainty, audit scope or accounting principle.

         (iii) In connection with its audits for the two most recent fiscal
         years and through November 17, 2003, there have been no disagreements
         with PricewaterhouseCoopers LLP on any matter of accounting principles
         or practices, financial statement disclosure, or auditing scope or
         procedure, which disagreements if not resolved to the satisfaction of
         PricewaterhouseCoopers LLP would have caused them to make reference
         thereto in their report on the financial statements for such years.

         (iv) The Registrant has requested that PricewaterhouseCoopers LLP
         furnish it with a letter addressed to the SEC stating whether or not it
         agrees with the above statements. A copy of such letter, dated November
         20,2003, is filed as Exhibit 16 to this Form 8-K.

(b)      New independent accountants

         (i) The Registrant engaged Rubin Brown Gornstein & Co. LLP. as its new
         independent accountants as of November 17, 2003. During the two most
         recent fiscal years and through November 17, 2003, the Registrant has
         not consulted with Rubin Brown Gornstein & Co. LLP. regarding either
         (i) the application of accounting principles to a specified
         transaction, either completed or proposed; or the type of audit opinion
         that might be rendered on the Registrant's financial statements, and
         neither a written report was provided to the Registrant or oral advice
         was provided that Rubin Brown Gornstein & Co. LLP concluded was an
         important factor considered by the Registrant in reaching a decision as
         to the accounting, auditing or financial reporting issue; or (ii) any
         matter that was either the subject of a disagreement, as that term is
         defined in item 304(a)(1)(iv) of Regulation S-K and the related
         instructions to item 304 of Regulation S-K, or a reportable event, as
         that term is defined in item 304(a)(1)(v) of Regulation S-K.

Item 7 - Financial Statements and Exhibits.

         (A)  Not Applicable

         (B)  Not Applicable

         (C)  Exhibits

              Exhibit 16 - Letter re change in certifying accountant.


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       Allied Healthcare Products, Inc.

                                       By:  /s/ Daniel C. Dunn

                                       Name: Daniel C. Dunn
                                       Its:  Chief Financial Officer

November 20, 2003